Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: A randomized, double-blind, placebo-controlled trial in Chinese males and females

Autor: Li, Rongcheng1 lrch2001@163.com, Li, Yanping1 lyp898@163.com, Radley, David2 david_radley@merck.com, Liu, Youping3 lyp95053@163.com, Huang, Teng1 huangt24@hotmail.com, Sings, Heather L.2 heather_sings@merck.com, Zhang, Lingling4 cathy_zhang@merck.com, Wang, Wei4 wwpedd.chen@gmail.com, Zhong, Xiang4 xiang.zhong@merck.com, Saah, Alfred J.2 alfred_saah@merck.com
Zdroj: Vaccine. Jun2012, Vol. 30 Issue 28, p4284-4291. 8p.
Databáze: Academic Search Ultimate
Externí odkaz: